{"url_path":"/sec/jagx/8-k/2026-04-27/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1585608/0001193125-26-179391-index.html","accession_number":"0001193125-26-179391","cik":"0001585608","ticker":"JAGX","issuer_name":"Jaguar Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1585608/0001193125-26-179391-index.html","primary_entity_key":"0001585608","primary_entity_name":"Jaguar Health, Inc."},"word_count":103,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\nNo.\n  \n\nDescription\n\n3.1\n  \n[Certificate of Eleventh Amendment of the Third Amended and Restated Certificate of Incorporation of Jaguar Health, Inc.](d109088dex31.htm)\n\n99.1\n  \n[Press Release Announcing Reverse Stock Split dated April 27, 2026.](d109088dex991.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \nJAGUAR HEALTH, INC.\n\nDate: April 27, 2026\n \n\n \nBy:\n \n\n/s/ Lisa A. Conte\n\n \n\n \n\n \n\nLisa A. Conte\n\nChief Executive Officer & President"}